Regional Lead, Patient Access, KRYSTEXXA (Rare Disease) Southeast
Amgen
About this role
The Regional Lead, Patient Access for KRYSTEXXA is a senior commercial role at Amgen focused on supporting patient access initiatives for the KRYSTEXXA product and aligning field-based patient access services with broader company strategy. The position advances Amgen’s mission to serve patients with serious illnesses across oncology, inflammation, general medicine, and rare disease areas.
Skills
Qualifications
About Amgen
amgen.comAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Recent company news
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers
2 days ago
Franklin Resources Inc. Lowers Position in Amgen Inc. $AMGN
4 hours ago
Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference
13 hours ago
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
3 days ago
About Amgen
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Amgen.
Salary
$194k – $224k
per year
More jobs at Amgen
Similar Jobs
Regional Account Manager – Rare Disease - South Central Region
Kyowa Kirin
Regional Account Manager – Rare Disease - Southeast Region
Kyowa Kirin
Regional Account Partner, Rare Disease
AstraZeneca
Regional Rare Disease Lead Epilepsy - Lombardia & Emilia Romagna
City of Pierre, South Dakota
Field Access Director, Rare Disease, Central
Ipsen
Director, US Rare Disease Access Strategy
Sanofi